期刊
PSYCHIATRIC CLINICS OF NORTH AMERICA
卷 33, 期 4, 页码 905-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.psc.2010.09.003
关键词
Postconscussive traumatic brain injury; MicroRNA; Biomarker; Personalized medicine
类别
Patients who have sustained a mild traumatic brain injury (TBI) from both civilian and military populations exhibit clinical symptoms of varying severity with minimal to profound impact on their daily functioning Although most patients make a full recovery, a subgroup of mild TBI patients develop cognitive somatic, and neurobehavioral sequelae that generally resolve over 3 to 6 months a smaller subgroup develop persisting symptoms The reason why a mild TBI results in varying clinical symptoms is currently unknown Based on evidence that microRNA species in peripheral blood mononuclear cells (PBMCs) may reflect molecular alterations in neurodegenerative disorders it can be hypothesized that at early preclinical phases of the disease PBMC may provide an ideal and clinically assessable window' into the brain Thus it is conceivable that changes in the expression profile of clinically accessible biological indices (biomarkers) such as microRNA in PBMC may reflect molecular alterations
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据